As of January 22, 2025, Bicycle Therapeutics (BCYC) has a market cap of $0.90 billion USD. According to our data, Bicycle Therapeutics is ranked No.5355 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.90 B |
35.60%
|
Dec 31, 2024 | $0.67 B |
-22.57%
|
Dec 29, 2023 | $0.86 B |
-38.92%
|
Dec 30, 2022 | $1.41 B |
-51.37%
|
Dec 31, 2021 | $2.89 B |
239.11%
|
Dec 31, 2020 | $0.85 B |
90.35%
|
Dec 31, 2019 | $0.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Molecular Partners
MOLN
|
$0.20 B |
-0.000 M
|
Switzerland
|
Sutro Biopharma
STRO
|
$0.16 B |
0.338 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
CytomX Therapeutics
CTMX
|
$65.55 M |
0.000 M
|
USA
|
Pieris Pharmaceuticals
PIRS
|
$17.96 M |
0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.20 B |
-0.000 M
|
USA
|
Adagene
ADAG
|
$79.91 M |
0.000 M
|
China
|
Mersana Therapeutics
MRSN
|
$64.24 M |
-0.000 M
|
USA
|
IGM Biosciences
IGMS
|
$0.10 B |
43.006 M
|
USA
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Xencor
XNCR
|
$1.45 B |
0.000 M
|
USA
|
Affimed
AFMD
|
$18.03 M |
0.000 M
|
Germany
|
Avidity Biosciences
RNA
|
$3.59 B |
-0.000 M
|
USA
|
Market Cap | = | BCYC Stock Price | * | BCYC Shares Outstanding |
= | $13.07 | * | 47.55 M | |
= | $0.90 B |